Impairments in endocannabinoid signaling and depressive illness.
paper
Cited
Public
Unavailable
- Authors
- Hill, Matthew N; Gorzalka, Boris B
- Year
- 2009
- Journal
- JAMA
- PMID
- 19293417
- DOI
- 10.1001/jama.2009.369
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Role of astrocyte in neuroinflammation-induced loss in neuroplasticity and subsequent onset of depression: A systematic review. | Singhal G et al. | β | 2025 | β |
| Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review. | Fuentes JJ et al. | β | 2024 | β |
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | Preuss UW et al. | β | 2023 | β |
| Could serum endocannabinoid and N-acylethanolamine levels be important in bipolar disorder? | Topuz RD et al. | β | 2023 | β |
| Disruption of tonic endocannabinoid signalling triggers cellular, behavioural and neuroendocrine responses consistent with a stress response. | Petrie GN et al. | β | 2023 | β |
| Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review. | Hasbi A et al. | β | 2023 | β |
| The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses. | Hill MN et al. | β | 2023 | β |
| Targeting the Endocannabinoid System in the Treatment of Posttraumatic Stress Disorder: A Promising Case of Preclinical-Clinical Translation? | Mayo LM et al. | β | 2022 | β |
| Neurobiological Processes Induced by Aerobic Exercise through the Endocannabinoidome. | Forteza F et al. | β | 2021 | β |
| Circulating endocannabinoid concentrations in grieving adults. | Harfmann EJ et al. | β | 2020 | β |
| Curcumin in Depression: Potential Mechanisms of Action and Current Evidence-A Narrative Review. | Ramaholimihaso T et al. | β | 2020 | β |
| Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system. | Chevalier G et al. | β | 2020 | β |
| Elevated Anandamide, Enhanced Recall of Fear Extinction, and Attenuated Stress Responses Following Inhibition of Fatty Acid Amide Hydrolase: A Randomized, Controlled Experimental Medicine Trial. | Mayo LM et al. | β | 2020 | β |
| An endocannabinoid receptor polymorphism modulates affective processing under stress. | Wirz L et al. | β | 2018 | β |
| Cannabis regulatory science: risk-benefit considerations for mental disorders. | Borodovsky JT et al. | β | 2018 | β |
| Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana. | Feingold D et al. | β | 2017 | β |
| Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study. | Kranaster L et al. | β | 2017 | β |
| Major depressive disorder, suicidal thoughts and behaviours, and cannabis involvement in discordant twins: a retrospective cohort study. | Agrawal A et al. | β | 2017 | β |
| Microglia: An Interface between the Loss of Neuroplasticity and Depression. | Singhal G et al. | β | 2017 | β |
| Interaction between interleukin-1Ξ² and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis. | Gentile A et al. | β | 2016 | β |
| Cannabinoid modulation of drug reward and the implications of marijuana legalization. | Covey DP et al. | β | 2015 | β |
| Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: the role of the endocannabinoid system. | Wang HN et al. | β | 2014 | β |
| Cannabis controversies: how genetics can inform the study of comorbidity. | Agrawal A et al. | β | 2014 | β |
| Have the genetics of cannabis involvement gone to pot? | Agrawal A et al. | β | 2014 | β |
| Hypothalamic-pituitary-adrenocortical axis: neuropsychiatric aspects. | Jacobson L | β | 2014 | β |
| The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. | Lev-Ran S et al. | β | 2014 | β |
| Ξ²-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. | Bahi A et al. | β | 2014 | β |
| Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti rats. | Petschner P et al. | β | 2013 | β |
| Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses. | Hill MN et al. | β | 2013 | β |
| Antidepressant-like effects of ΞβΉ-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression. | Elbatsh MM et al. | β | 2012 | β |
| Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists. | Janero DR | β | 2012 | β |
| Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression. | Agrawal A et al. | β | 2012 | β |
| Cannabinoids and emotionality: a neuroanatomical perspective. | McLaughlin RJ et al. | β | 2012 | β |
| Circulating endocannabinoid concentrations and sexual arousal in women. | Klein C et al. | β | 2012 | β |
| Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis. | Hill MN et al. | β | 2012 | β |
| Expression pattern of the cannabinoid receptor genes in the frontal cortex ofΒ mood disorder patients and mice selectively bred for high and low fear. | Choi K et al. | β | 2012 | β |
| Interleukin-1Ξ² causes anxiety by interacting with the endocannabinoid system. | Rossi S et al. | β | 2012 | β |
| Neurobiology of chronic mild stress: parallels to major depression. | Hill MN et al. | β | 2012 | β |
| Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma. | Zoerner AA et al. | β | 2011 | β |
| Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress. | Hill MN et al. | β | 2011 | β |
| Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance. | Maccarrone M et al. | β | 2011 | β |
| Personalized medicine can pave the way for the safe use of CBβ receptor antagonists. | Lazary J et al. | β | 2011 | β |
| Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants. | Gorzalka BB et al. | β | 2011 | β |
| Endocannabinoids differentially modulate synaptic plasticity in rat hippocampal CA1 pyramidal neurons. | Xu JY et al. | β | 2010 | β |
| Evaluating the effect of Cannabis sativa seed extraction on memory | Yazdi A et al. | β | 2010 | β |
| Inhibition of monoamine oxidase activity by cannabinoids. | Fisar Z | β | 2010 | β |
| Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. | Topol EJ et al. | β | 2010 | β |
| Discontinued drugs in 2008: endocrine and metabolic. | Colca JR | β | 2009 | β |